The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Haraf, Daniel J.
One or more keywords matched the following items that are connected to Haraf, Daniel J.
Item TypeName
Concept Neoplasm Recurrence, Local
Academic Article Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
Academic Article Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Academic Article Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Academic Article Oral 5-FU alternatives for the treatment of head and neck cancer.
Academic Article Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
Academic Article Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer.
Academic Article Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer.
Academic Article Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.
Academic Article Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Academic Article Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Academic Article Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Academic Article Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Academic Article Reirradiation of recurrent head and neck cancers with curative intent.
Academic Article Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Academic Article Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Academic Article Free-flap reconstruction in the doubly irradiated patient population.
Academic Article Planned post-chemoradiation neck dissection: significance of radiation dose.
Academic Article Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Academic Article Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
Academic Article The role of paclitaxel in the treatment of head and neck cancer.
Academic Article Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
Academic Article Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Academic Article Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
Academic Article Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Academic Article Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
Academic Article Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.
Search Criteria
  • Neoplasm Recurrence Local